Abstract
Graft rejection is an important cause of renal allograft dysfunction and requires antirejection therapy (ART) for its reversal. However, it is associated with risk of over-immunosuppression, which is often underestimated against improved graft outcome. In this study we aim to assess the complications attributed to ART in a cohort of renal allograft recipients (RAR) out of hospital based renal transplant registry (RTR).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
